KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Cash from Investing Activities (2016 - 2022)

TherapeuticsMD filings provide 12 years of Cash from Investing Activities readings, the most recent being -$74000.0 for Q4 2022.

  • On a quarterly basis, Cash from Investing Activities rose 95.11% to -$74000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was -$355000.0, a 84.03% increase, with the full-year FY2022 number at -$355000.0, up 84.03% from a year prior.
  • Cash from Investing Activities hit -$74000.0 in Q4 2022 for TherapeuticsMD, down from $7000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $7000.0 in Q3 2022 to a low of -$20.7 million in Q4 2019.
  • Median Cash from Investing Activities over the past 5 years was -$418500.0 (2020), compared with a mean of -$2.5 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 28077.04% in 2018 and later soared 103.85% in 2022.
  • TherapeuticsMD's Cash from Investing Activities stood at -$671171.0 in 2018, then plummeted by 2986.19% to -$20.7 million in 2019, then soared by 97.62% to -$494000.0 in 2020, then plummeted by 206.48% to -$1.5 million in 2021, then surged by 95.11% to -$74000.0 in 2022.
  • The last three reported values for Cash from Investing Activities were -$74000.0 (Q4 2022), $7000.0 (Q3 2022), and -$76000.0 (Q2 2022) per Business Quant data.